Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Current Protocols in Human Genetics|July 13, 2012
Morphology antibody chromosome technique for determining phenotype and genetic status of the same cellSakari Knuutila, Satu MustjokiExpert Review of Hematology|November 19, 2010
Suboptimal responses in chronic myeloid leukemia: milestones and mechanismsKimmo Porkka, Satu Mustjoki, Bengt SimonssonDuodecim; Laaketieteellinen Aikakauskirja|November 22, 2017
LGL leukemia and autoimmunity - the borderline between autoimmune disease and cancer is becoming blurredPaula Savola, Hanna Rajala, Satu MustjokiMolecular Cytogenetics|July 23, 2013
Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemiaNeda Mosakhani, Satu Mustjoki, Sakari KnuutilaBritish Journal of Haematology|April 25, 2009
Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemiaFranz Gruber, Satu Mustjoki, Kimmo PorkkaEuropean Journal of Haematology|July 29, 2010
Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapyPeter Rohon, Kimmo Porkka, Satu MustjokiOncoimmunology|July 23, 2014
IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemiaMette Ilander, Anna Kreutzman, Satu MustjokiCurrent Hematologic Malignancy Reports|January 7, 2014
Immunology and immunotherapy of chronic myeloid leukemiaMette Ilander, Can Hekim, Satu MustjokiLeukemia & Lymphoma|May 4, 2021
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemiaShady Adnan-Awad, Matti Kankainen, Satu MustjokiDuodecim; Laaketieteellinen Aikakauskirja|April 18, 2012
[Current therapy of chronic myeloid leukemia]Hanna Koskela, Perttu Koskenvesa, Satu Mustjoki, et al.Pageof 18